Many people live with two serious heart conditions at the same time. They have atrial fibrillation, which makes their heart beat irregularly, and coronary artery disease, which means their heart arteries are narrowed by plaque. To prevent strokes and heart attacks, doctors often prescribe two blood-thinning medicines at once. This approach is called dual antithrombotic therapy. But taking two strong medicines increases the risk of dangerous bleeding. This research asks if taking just one medicine, edoxaban, could be just as safe and effective.
The study team looked at data from a large group of 1,040 patients. These individuals had both heart rhythm problems and blocked arteries. They were already taking edoxaban, a specific type of blood thinner. Some patients took edoxaban alone, while others took edoxaban plus a second antiplatelet agent. The team tracked these patients for 12 months to see who had bad events. These events included death, heart attacks, strokes, or major bleeding.
The results show a clear difference between the two treatment plans. Patients taking edoxaban by itself had much fewer bad events than those taking two medicines. In patients with a specific type of irregular heartbeat called paroxysmal AF, the risk of a bad event was 4.6% with one medicine versus 16.2% with two. For patients with a different pattern of irregular heartbeat, the risk was 9.3% with one medicine versus 15.0% with two. The study also found that the type of irregular heartbeat did not change these results.
Safety was a major focus of this research. The primary goal was to measure net adverse clinical events. This is a combined score that counts both life-threatening bleeding and other serious health issues like heart attacks or strokes. The data clearly shows that the single-medicine group had a much lower rate of these combined problems. The researchers did not report specific details on side effects or how many people stopped the medicine early, but the overall safety profile looked better for the single-drug group.
It is important not to get too excited about this single study. It only followed patients for one year. We do not yet know if these benefits last for five or ten years. Also, this group of 1,040 patients might not represent every patient in the world. Doctors should not stop prescribed medicines based on this news alone. Patients must talk to their doctor about their specific situation before making any changes to their medication plan.
What does this mean for patients right now? It suggests that for some people with both heart rhythm issues and blocked arteries, taking one blood thinner might be a safer option than taking two. This could mean less worry about bleeding and a simpler daily routine. However, every patient is different. Your doctor knows your full history and must decide the best plan for you. This study offers hope for simpler, safer treatment, but it is just one piece of the puzzle.